Evaluation of the Deadly Liver Mob program: insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care
Tóm tắt
Deadly Liver Mob (DLM) is a peer-driven, incentivised health promotion program aimed at increasing understanding of hepatitis C, promoting harm reduction in relation to injecting drug use, and linking participants to screening for hepatitis C, other blood borne viruses and sexually transmissible infections among Aboriginal people in Western Sydney, NSW. This paper presents the evaluation of a pilot study examining the acceptability of the program as a first step of a scalability assessment. Deadly Liver Mob operated in co-located needle and syringe programs and sexual health clinics in two sites: (Site 1: two and a half years for 2 days/week; Site 2: 1 year for 1 day per week). Comparisons were made of the proportion of Aboriginal clients (Site 1) and occasions of service provided to Aboriginal clients (Site 2) in the 12 months prior and post-introduction of DLM. Interviews were conducted with 13 staff involved in delivery of DLM and with 19 clients. A total of 655 and 55 Aboriginal clients, respectively, attended Site 1 and Site 2 for health education. The proportion of Aboriginal clients attending both sites was significantly higher during the DLM compared with prior to its implementation. Of those attending for health education, 79 and 73%, respectively, attended screening following education. DLM clients strongly endorsed the program. Some staff were concerned about workforce capacity to effectively engage Aboriginal clients with multiple and complex needs, managing the differing aims of the participating services involved, and about offering of incentives for attendance at health services. While acceptability was high among staff and clients and preliminary results show high engagement with Aboriginal communities, this evaluation of a pilot program raises some issues to consider in scale up of DLM to other sites. The initiation of additional DLM sites should address issues of alignment with governing strategies and workforce capacity.
Tài liệu tham khảo
World Health Organization. Nine steps for developing a scaling-up strategy. Geneva: World Health Organization; 2010.
Centre for Epidemiology and Evidence, Milat A, Newson R, King L. Increasing the scale of population health interventions: a guide. Sydney: NSW Ministry of Health; 2014.
NHMRC. The NHMRC road map II: a strategic framework for improving the health of Aboriginal and Torres Strait islander people through research. Commonwealth of Australia: Canberra; 2010.
Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait islander peoples: 2015 [internet]. Canberra: Australian Institute of Health and Welfare; 2015.
NSW Department of Health. NSW HIV/AIDS, STIs and hepatitis C strategies: implementation plan for Aboriginal people, 2006–2009. Sydney: NSW Department of Health; 2007.
Australian Govt Dept of Health. Fourth National Aboriginal and Torres Strait islander blood-borne viruses and sexually transmissible infections strategy 2014–2017. Canberra: Australian Govt Dept of Health; 2014.
Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis Hepatitis C Sub-Committee. Hepatitis C virus projections working group: estimates and projections of the hepatitis C virus epidemic in Australia 2006. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2006.
The Kirby Institute. Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait islander people: annual surveillance report 2016. Sydney: The Kirby Institute, UNSW Australia; 2016.
The Kirby Institute. Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait islander people: surveillance and evaluation report 2013. Sydney: Kirby Institute, the University of New South Wales; 2013.
Treloar C, Jackson LC, Gray R, Newland J, Wilson H, Saunders V, et al. Multiple stigmas, shame and historical trauma compound the experience of Aboriginal Australians living with hepatitis C. Health Sociol Rev. 2016;25(1):18–32. https://doi.org/10.1080/14461242.2015.1126187.
Ward J, Goller J, Ali H, Bowring A, Couzos S, Saunders M, et al. Chlamydia among Australian Aboriginal and/or Torres Strait islander people attending sexual health services, general practices and Aboriginal community controlled health services. BMC Health Serv Res. 2014;14:285. Epub 2014/07/02. doi: 10.1186/1472-6963-14-285. PubMed PMID: 24981418; PubMed Central PMCID: PMCPmc4094446
O'Connor C, Ali H, Guy R, Templeton D, Fairley C, Chen M, et al. High chlamydia positivity rates in indigenous people attending Australian sexual health services. Med J Aust. 2014;200(10):595–8.
Nutton J, Fast E. Historical trauma, substance use and Indigenous peoples: Seven generations of harm from a ‘Big Event’. Subst Use Misuse. 2015;50(7):839–47.
Sheaves F, Preston P, O'Neil E, Klein G, Hart K. That’s SIC: mobilising youth for hepatitis C prevention. Health Promot J Austr. 2001;12(3):217–22.
Broadhead RS, Heckathorn DD, Altice FL, van Hulst Y, Carbone M, Friedland GH, et al. Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med. 2002;55(2):235–46. doi: http://dx.doi.org/10.1016/S0277-9536(01)00167-8
Broadhead RS, Heckathorn DD, Grund J-PC, Stern LS, Anthony DL. Drug users versus outreach workers in combating AIDS: preliminary results of a peer-driven intervention. J Drug Iss. 1995;25(3):531–64.
Sergeyev B, Oparina T, Rumyantseva TP, Volkanevskii VL, Broadhead RS, Heckathorn DD, et al. HIV prevention in Yaroslavl, Russia: a peer-driven intervention and needle exchange. J Drug Issues. 1999;29(4):777–803. https://doi.org/10.1177/002204269902900403.
Bessarab D, Ng’andu B. Yarning about yarning as a legitimate method in indigenous research. Int J Crit Indigenous Stud. 2010;3(1):37–50.
Couzos S, Murray R. Aboriginal primary health care: an evidence-based approach. South Melbourne: Oxford University Press; 2007.
Biggs K, Walsh J, Ooi C. Deadly Liver Mob: opening the door ? Improving sexual health pathways for Aboriginal people in western Sydney. Sex Health. 2016; Epub 2016/07/04. doi: 10.1071/sh15176. PubMed PMID: 27371995.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. https://doi.org/10.1191/1478088706qp063oa.
Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for reporting implementation studies (StaRI): explanation and elaboration document. BMJ Open. 2017;7(4):e013318. https://doi.org/10.1136/bmjopen-2016-013318. PubMed PMID: PMC5387970
Milat AJ, Newson R, King L, Rissel C, Wolfenden L, Bauman A, et al. A guide to scaling up population health interventions. Public Health Res Pract. 2016;26(1):e2611604. Epub 2016/02/11. doi: 10.17061/phrp2611604. doi: 10.17061/phrp2541543. PubMed PMID: 26863167
NSW Ministry of Health. NSW HIV strategy, 2016–2020. Sydney: NSW Ministry of Health; 2016.
NSW Ministry of Health. NSW hepatitis C strategy 2014–2020. Sydney: NSW Ministry of Health; 2014.
NSW Ministry of Health. NSW sexually transmissible infection strategy, 2016–2020. Sydney: NSW Ministry of Health; 2016.
Boccia D, Hargreaves J, Lonnroth K, Jaramillo E, Weiss J, Uplekar M, et al. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011;15(Suppl 2):S37–49. doi: 10.5588/ijtld.10.0438. PubMed PMID: 21740658; PubMed Central PMCID: PMC3160484
Lagarde M, Haines A, Palmer N. Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: a systematic review. JAMA. 2007;298(16):1900–10. doi: 10.1001/jama.298.16.1900. PubMed PMID: 17954541
Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16(7):1729–38. https://doi.org/10.1007/s10461-012-0240-z.
Robertson L, Mushati P, Eaton JW, Dumba L, Mavise G, Makoni J, et al. Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. The Lancet. 381(9874):1283–92. doi: https://doi.org/10.1016/S0140-6736(12)62168-0.
Hughes JJ. Paying injection drug users to educate and recruit their peers: why participant-driven interventions are an ethical public health model. Qual Manag Health Care. 1999;7(4):4–12. PubMed PMID: 10557398
Downing SG, Cashman C, McNamee H, Penney D, Russell DB, Hellard ME. Increasing chlamydia test of re-infection rates using SMS reminders and incentives. Sex Transm Infect. 2013;89(1):16–9. https://doi.org/10.1136/sextrans-2011-050454.
Parker RM, Bell A, Currie MJ, Deeks LS, Cooper G, Martin SJ, et al. ‘Catching chlamydia’: combining cash incentives and community pharmacy access for increased chlamydia screening, the view of young people. Aust J Prim Health. 2015;21(1):79–83. doi: http://dx.doi.org/10.1071/PY12135
Topp L, Day CA, Wand H, Deacon RM, van Beek I, Haber PS, et al. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med. 2013;57(4):297–303. doi: http://dx.doi.org/10.1016/j.ypmed.2013.04.013
Fagan P, Cannon F, Crouch A. The young person check: screening for sexually transmitted infections and chronic disease risk in remote Aboriginal and Torres Strait islander youth. Aust N Z J Public Health. 2013;37(4):316–21. https://doi.org/10.1111/1753-6405.12078.
Metzl J, Hansen H. Structural competency: theorizing a new medical engagement with stigma and inequality. Soc Sci Med. 2014;103:126–33.
Brener L, Wilson H, Jackson LC, Johnson P, Saunders V, Treloar C. Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C. Aust N Z J Public Health. 2016;40(S1):S59–64. https://doi.org/10.1111/1753-6405.12402.
Treloar C, Jackson C, Gray R, Newland J, Wilson H, Saunders V, et al. Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: implications for the implementation of new treatments. Ethn Health. 2016;21(1):39–57. https://doi.org/10.1080/13557858.2015.1004870.
Hunter B, Jordan K. Explaining social exclusion: towards social inclusion for indigenous Australians. Aust J Soc Issues. 2010;45(2):243–65.
Goffman E. Stigma: notes on the management of spoiled identity. New York, NY: Simon and Schuster; 1963.
Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24. doi: http://dx.doi.org/10.1016/S0277-9536(02)00304-0
Crawford R. Healthism and the Medicalization of everyday life. Int J Health Serv. 1980;10(3):365–88. https://doi.org/10.2190/3h2h-3xjn-3kay-g9ny.
Crawford R. Health as a meaningful social practice. Health. 2006;10(4):401–20. https://doi.org/10.1177/1363459306067310.
Stangl AL, Lloyd JK, Brady LM, Holland CE, Baral S. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? J Int AIDS Soc. 2013;16(3 Suppl 2):18734. Epub 2013/11/28. doi: 10.7448/ias.16.3.18734. PubMed PMID: 24242268; PubMed Central PMCID: PMCPmc3833106